Disse data er blevet evalueret af referencemedlemsstaten (MHRA), og der er blevet identificeret en øget risiko for selvmordstanker og suicidal adfærd hos børn behandlet med atomoxetin.
These data have been evaluated by the Reference Member State (MHRA) and has identified an increased risk of suicidal thoughts and behaviour in children treated with Atomoxetine.